Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic drug "identical" dosage definition is at FDA's discretion, Pfizer law firm contends.

Executive Summary

GENERIC DRUG "IDENTICAL" DOSAGE DEFINITION IS AT FDA's DISCRETION, the Washington, D.C. law firm Wiley, Rein & Fielding said in Feb. 3 comments submitted to FDA on behalf of Pfizer. Congress has delegated to FDA, "exercising considered discretion...to decide when dosage form was identical," Wiley, Rein & Fielding stated. The comments respond to a Nov. 18 letter from the Generic Pharmaceutical Industry Association on the issue of comparability of dosage forms ("The Pink Sheet" Dec. 5, 1994, T&G-10).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel